Jerry (J) Janssen PhD


BSc Biomedical Sciences, MSc Oncology, PhD

Research interests

  • B-cell Immunology
  • hemato-oncology
  • antigen-specific B-cell responses


  • FACS
  • Cell-based assays
  • Immunohistochemistry



Postdoctoral fellow at Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands


PhD candidate at Department of Pathology, Amsterdam UMC, Amsterdam Medical Center, The Netherlands


MSc Oncology, VU University of Amterdam, The Netherlands


BSc Biomedical Sciences, VU University of Amsterdam, The Netherlands

Other publications

  • Bende RJ, Janssen J, Beentjes A, Wormhoudt TAM, Wagner K, Haacke EA, et al. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjogren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG. Arthritis Rheumatol. 2020
  • Dyczynski M, Vesterlund M, Bjorklund AC, Zachariadis V, Janssen J, Gallart-Ayala H, et al. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment.  Cell Death Dis. 2018;9(9):846
  • Bende RJ, Janssen J, Wormhoudt TA, Wagner K, Guikema JE, van Noesel CJ. Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity. Haematologica. 2016;101(5):e200-3
  • Voorham QJ, Janssen J, Tijssen M, Snellenberg S, Mongera S, van Grieken NC, et al. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas. BMC Cancer. 2013;13:603